Bluejay Diagnostics (BJDX) Times Interest Earned (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Times Interest Earned of -$19.39 for Q1 2026, up 60.73% on a YoY basis from -$12.06 in Q1 2025, and up 99.75% sequentially from -$7816.8 in Q4 2025.
Bluejay Diagnostics (BJDX) Times Interest Earned (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 7 years of Times Interest Earned data on file, last reported at -$19.39 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 60.73% year-over-year to -$19.39; the trailing twelve-month figure through Mar 2026 stood at -$70.03 (down 1515.41% YoY), and the FY2025 full-year result was -$0.58, up 19.5% from the prior year.
- Times Interest Earned climbed to -$19.39 in Q1 2026, from -$7816.8 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$2.2 in Q4 2024 to a low of -$7816.8 in Q4 2025.
- A 5-year average of -$539.42 and a median of -$54.31 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned jumped 98.43% in 2024 and plunged 354850.7% in 2025, its largest moves.
- Tracing BJDX's Times Interest Earned over 5 years: stood at -$67.01 in 2022, then climbed by 18.95% to -$54.31 in 2023, then surged by 95.94% to -$2.2 in 2024, then sank by 354850.7% to -$7816.8 in 2025, then soared by 99.75% to -$19.39 in 2026.
- Business Quant data shows BJDX's Times Interest Earned at -$19.39 in Q1 2026, -$7816.8 in Q4 2025, and -$230.73 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | -19.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.39 |
| Dec 31, 2025 | -7,816.83 |
| Sep 30, 2025 | -230.73 |
| Jun 30, 2025 | -206.31 |
| Mar 31, 2025 | -49.37 |
| Dec 31, 2024 | -2.20 |
| Sep 30, 2024 | -7.14 |
| Jun 30, 2024 | -3.03 |
| Mar 31, 2024 | -54.92 |
| Dec 31, 2023 | -54.31 |
| Sep 30, 2023 | -455.40 |
| Jun 30, 2023 | -29.04 |
| Mar 31, 2023 | -61.51 |
| Dec 31, 2022 | -67.01 |
| Sep 30, 2022 | -28.10 |
| Jun 30, 2022 | -14.16 |
| Mar 31, 2022 | -70.71 |
| Dec 31, 2021 | -12.34 |
| Sep 30, 2021 | -1.31 |
| Jun 30, 2021 | -28.56 |